Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Chemical Sympathectomy in Hand Vascular Disease
NCT02374320Phase 3Terminated
- Start
- Nov 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal bupivacaine in limited cutaneous systemic sclerosis (lcSSc), peripheral vascular disease (PVD), Raynaud disease, Diffuse Systemic Sclerosis (SSc). Started Nov 2014; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
limited cutaneous systemic sclerosis (lcSSc)peripheral vascular disease (PVD)Raynaud diseaseDiffuse Systemic Sclerosis (SSc)
Beyond the preview
Go deeper on NCT02374320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374320.